ALFUZOSIN Side Effects

5421117-9 | Cerebral Haemorrhage
on Aug 10, 2007 Male patient from JAPAN , weighting 169.8 lb, was diagnosed with benign prostatic hyperplasia, tinea cruris, hypertension, nasopharyngitis, gastritis prophylaxis, sciatica (What is sciatica?), constipation (What is constipation?) and was treated with Alfuzosin (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage. Alfuzosin dosage: . During the same period patient was treated with BIFONAZOLE (Adequate Amount) (View Bifonazole Review and Bifonazole Label ), CANDESARTAN CILEXETIL (Unk) (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), KAKKONTO (7.5 G) (View Kakkonto Review and Kakkonto Label ), REBAMIPIDE (300 Mg) (View Rebamipide Review and Rebamipide Label ), LIMAPROST ALFADEX (0.5 Mg) (View Limaprost Alfadex Review and Limaprost Alfadex Label ), LOXOPROFEN SODIUM (180 Mg) (View Loxoprofen Sodium Review and Loxoprofen Sodium Label ), MAGNESIUM OXIDE (330 Mg) (View Magnesium Oxide Review and Magnesium Oxide Label ). Patient was hospitalized.

5349340-2 | Cerebral Haemorrhage
Patient was taking Alfuzosin (View Usage). Patient had the following side effects: cerebral haemorrhage on Jun 06, 2007 from JAPAN Additional patient health information: Male patient , weighting 169.8 lb, was diagnosed with benign prostatic hyperplasia, tinea cruris, hypertension, nasopharyngitis, gastritis prophylaxis, sciatica (What is sciatica?), constipation (What is constipation?) and. Alfuzosin dosage: . During the same period patient was treated with BIFONAZOLE (Adequate Amount) (View Bifonazole Review and Bifonazole Label ), CANDESARTAN CILEXETIL (Unk) (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), KAKKONTO (7.5 G) (View Kakkonto Review and Kakkonto Label ), REBAMIPIDE (300 Mg) (View Rebamipide Review and Rebamipide Label ), LIMAPROST ALFADEX (0.5 Mg) (View Limaprost Alfadex Review and Limaprost Alfadex Label ), LOXOPROFEN SODIUM (180 Mg) (View Loxoprofen Sodium Review and Loxoprofen Sodium Label ), MAGNESIUM OXIDE (330 Mg) (View Magnesium Oxide Review and Magnesium Oxide Label ). Patient was hospitalized.

5324001-4 | Blood Pressure Diastolic Decreased, Syncope
Adverse event was reported on May 09, 2007 by a Male patient taking Alfuzosin (View Usage) (Dosage: 10mg Po Qhs) was diagnosed with benign prostatic hyperplasia and. Location: UNITED STATES , 79 years of age, After Alfuzosin was administered, patient had the following side effects: blood pressure diastolic decreased, syncope. During the same period patient was treated with TERAZOSIN HCL (5mg Po Qhs) (View Terazosin Hcl Review and Terazosin Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BRIMONIDINE EYE DROPS (View Brimonidine Eye Drops Review and Brimonidine Eye Drops Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ), DORZOLAMIDE/TIMOLOL EYE DROPS (View Dorzolamide/timolol Eye Drops Review and Dorzolamide/timolol Eye Drops Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), FINASTERIDE (View Finasteride Review and Finasteride Label ), SYNTHROID (View Synthroid Review and Synthroid Label ). Patient was hospitalized.

5277235-1 | Dizziness, Vision Blurred
on Mar 22, 2007 Male patient from UNITED STATES , 83 years of age, was treated with Alfuzosin (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), vision blurred. Alfuzosin dosage: 10mg Every Day Po.


5082597-4 | Bacteraemia, Pseudomonal Bacteraemia, Renal Failure Acute, Septic Shock, Toxic Epidermal Necrolysis
on Aug 07, 2006 Male patient from SINGAPORE , 80 years of age, was diagnosed with benign prostatic hyperplasia and was treated with Alfuzosin (View Usage). Patient had the following side effects: bacteraemia, pseudomonal bacteraemia, renal failure acute, septic shock, toxic epidermal necrolysis. Alfuzosin dosage: Unk. Patient was hospitalized.

4870256-X | Cataract Operation Complication, Iris Disorder
Patient was taking Alfuzosin (View Usage). After Alfuzosin was administered, patient had the following side effects: cataract operation complication, iris disorder on Dec 21, 2005 from UNITED KINGDOM Additional patient health information: Male patient , 69 years of age, was diagnosed with benign prostatic hyperplasia and. Alfuzosin dosage: .

4736905-1 | Hepatitis Acute, Jaundice
Adverse event was reported on Jul 27, 2005 by a Male patient taking Alfuzosin (View Usage) (Dosage: 10 Mg) was diagnosed with prostate cancer (What is prostate cancer?), glaucoma (What is glaucoma?) and. Location: UNITED KINGDOM , 84 years of age, Patient experienced the following unwanted or unexpected effects: hepatitis acute, jaundice (What is jaundice?). During the same period patient was treated with TIMOPTIC (Unk) (View Timoptic Review and Timoptic Label ). Patient was hospitalized.

4723747-6 | Hypotension
on Jul 20, 2005 Male patient from UNITED STATES , 74 years of age, was treated with Alfuzosin (View Usage). Patient had the following side effects: hypotension. Alfuzosin dosage: 10 Mg Po Qd. During the same period patient was treated with CARBIDOPA + LEVODOPA (3 Q Am 2 At Noon) (View Carbidopa + Levodopa Review and Carbidopa + Levodopa Label ), NORTRIPTYLINE HCL (25mg Po Q Hs) (View Nortriptyline Hcl Review and Nortriptyline Hcl Label ), FENTANYL (100 Mg Q 72 Hrs.) (View Fentanyl Review and Fentanyl Label ). Patient was hospitalized.

4690411-1 | Angina Pectoris
on Jun 02, 2005 Male patient from , weighting 196.2 lb, was diagnosed with benign prostatic hyperplasia and was treated with Alfuzosin (View Usage). After Alfuzosin was administered, patient had the following side effects: angina pectoris. Alfuzosin dosage: .

4687510-7 | Myocardial Infarction
Patient was taking Alfuzosin (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction on Jun 14, 2002 from Additional patient health information: Male patient , weighting 227.1 lb, . Alfuzosin dosage: . During the same period patient was treated with METFORMIN (2550 Mg) (View Metformin Review and Metformin Label ), ASPIRIN (300 Mg) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

4687508-9 | Acute Myocardial Infarction, Coronary Artery Occlusion, Heart Rate Decreased, Hypotension
Adverse event was reported on Dec 07, 2001 by a Male patient taking Alfuzosin (View Usage) (Dosage: ) . Location: , weighting 194.0 lb, Patient had the following side effects: acute myocardial infarction, coronary artery occlusion, heart rate decreased, hypotension. During the same period patient was treated with VASOTEC (10 Mg) (View Vasotec Review and Vasotec Label ), COUMADIN (5 Mg) (View Coumadin Review and Coumadin Label ), ATENOLOL (25 Mg) (View Atenolol Review and Atenolol Label ), ZOCOR (40 Mg) (View Zocor Review and Zocor Label ), ASPIRIN (80 Mg) (View Aspirin Review and Aspirin Label ), VITAMIN E (400 Iu) (View Vitamin E Review and Vitamin E Label ), ASCORBIC ACID (500 Mg) (View Ascorbic Acid Review and Ascorbic Acid Label ), MULTI VITAMINS (1 Unit) (View Multi-vitamins Review and Multi-vitamins Label ). Patient was hospitalized.

4687507-7 | Gastritis Hypertrophic
on Dec 09, 2002 Male patient from , weighting 178.6 lb, was treated with Alfuzosin (View Usage). After Alfuzosin was administered, patient had the following side effects: gastritis hypertrophic. Alfuzosin dosage: . During the same period patient was treated with ENALAPRIL MALEATE (10 Mg) (View Enalapril Maleate Review and Enalapril Maleate Label ), ACETYLSALICYLIC ACID (75 Mg) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ). Patient was hospitalized.

4687506-5 | Acute Myocardial Infarction, Coronary Artery Occlusion, Coronary Artery Stenosis, Fatigue
on Aug 30, 2002 Male patient from , weighting 191.8 lb, was treated with Alfuzosin (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, coronary artery occlusion, coronary artery stenosis, fatigue. Alfuzosin dosage: . During the same period patient was treated with SELOKEN (50 Mg) (View Seloken Review and Seloken Label ). Patient was hospitalized.

4687505-3 | Angina Pectoris, Hypertension, Myocardial Ischaemia
Patient was taking Alfuzosin (View Usage). Patient had the following side effects: angina pectoris, hypertension, myocardial ischaemia on Aug 30, 2002 from Additional patient health information: Male patient , weighting 180.8 lb, . Alfuzosin dosage: . During the same period patient was treated with METOPROLOL TARTRATE (50 Mg) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

4681522-5 | Myocardial Infarction
Adverse event was reported on Jan 16, 2003 by a Male patient taking Alfuzosin (View Usage) (Dosage: ) . Location: , weighting 231.5 lb, After Alfuzosin was administered, patient had the following side effects: myocardial infarction. During the same period patient was treated with DICLOFENAC SODIUM (25 Mg) (View Diclofenac Sodium Review and Diclofenac Sodium Label ), NITROGLYCERIN (Unk) (View Nitroglycerin Review and Nitroglycerin Label ), AMLODIPINE BESYLATE (5 Mg) (View Amlodipine Besylate Review and Amlodipine Besylate Label ). Patient was hospitalized.

4681521-3 | Acute Myocardial Infarction, Anaemia, Atrioventricular Block Second Degree, Condition Aggravated, Coronary Artery Occlusion, Coronary Artery Stenosis, Inflammation, Left Ventricular Failure, Oedema
on Dec 09, 2003 Male patient from , weighting 158.7 lb, was treated with Alfuzosin (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, anaemia, atrioventricular block second degree, condition aggravated, coronary artery occlusion, coronary artery stenosis, inflammation, left ventricular failure, oedema. Alfuzosin dosage: . Patient was hospitalized.

4681516-X | Syncope, Vertigo
on Jun 02, 2003 Male patient from , weighting 136.7 lb, was treated with Alfuzosin (View Usage). Patient had the following side effects: syncope, vertigo. Alfuzosin dosage: . During the same period patient was treated with ATACAND (8 Mg) (View Atacand Review and Atacand Label ), PLENDIL (25 Mg) (View Plendil Review and Plendil Label ). Patient was hospitalized.

4672615-7 | Syncope, Vertigo
Patient was taking Alfuzosin (View Usage). After Alfuzosin was administered, patient had the following side effects: syncope, vertigo on Jun 02, 2003 from Additional patient health information: Male patient , weighting 136.7 lb, . Alfuzosin dosage: . During the same period patient was treated with ATACAND (8 Mg) (View Atacand Review and Atacand Label ), PLENDIL (25 Mg) (View Plendil Review and Plendil Label ). Patient was hospitalized.

4654164-5 | Cholelithiasis, Pancreatitis, Pancreatitis Acute
Adverse event was reported on Aug 19, 2002 by a Male patient taking Alfuzosin (View Usage) (Dosage: ) . Location: , weighting 128.3 lb, Patient experienced the following unwanted or unexpected effects: cholelithiasis, pancreatitis, pancreatitis acute. During the same period patient was treated with CLAVULIN (875 Mg) (View Clavulin Review and Clavulin Label ), FLUVIRAL (1 Dose) (View Fluviral Review and Fluviral Label ), NASONEX (100 Mg) (View Nasonex Review and Nasonex Label ), CLONAZEPAM (2 Mg) (View Clonazepam Review and Clonazepam Label ), SYNTHROID (0.05 Mg) (View Synthroid Review and Synthroid Label ), ASPIRIN (81 Mg) (View Aspirin Review and Aspirin Label ), SCOPOLAMINE (1 Cap) (View Scopolamine Review and Scopolamine Label ), PANTOPRAZOLE SODIUM (40 Mg) (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ). Patient was hospitalized.

4575975-0 | Hepatitis A Antibody Positive, Hepatitis B Antibody Positive, Hepatitis Toxic
on Nov 03, 2004 Male patient from , 55 years of age, weighting 132.3 lb, was diagnosed with sexual dysfunction and was treated with Alfuzosin (View Usage). Patient had the following side effects: hepatitis a antibody positive, hepatitis b antibody positive, hepatitis toxic. Alfuzosin dosage: . Patient was hospitalized.